Trial Profile
Exparel (Bupivacaine Liposome Injectable Suspension) for Distal Upper Extremity Blocks in Orthopedic Surgery
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Apr 2017
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Mepivacaine
- Indications Pain
- Focus Therapeutic Use
- 21 Mar 2016 Planned End Date changed from 1 Feb 2016 to 1 Mar 2016, according to ClinicalTrials.gov record.
- 21 Mar 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Mar 2016, according to ClinicalTrials.gov record.
- 21 Mar 2016 Status changed from recruiting to discontinued, according to ClinicalTrials.gov record.